Showing results (431-440 of 668) with videos related to

Sort By:
Pageof 67
Diabetology International|January 4, 2019
Efficacy of switching from insulin glargine to insulin degludec in patients with type 1 diabetes: a 16-week retrospective studyJun Suzuki, Tadashi Yamakawa, Joe Nagakura, et al.
Diabetology International|January 4, 2019
Salt and hypertension in diabetesTakashi Uzu
Diabetology International|January 4, 2019
Clinical features of cases of seroconversion of anti-glutamic acid decarboxylase antibody during the clinical course of type 2 diabetes: a nationwide survey in JapanYoichi Oikawa, Akira Shimada, Takuya Awata, et al.
Diabetology International|January 4, 2019
Thermographic findings in a case of type 2 diabetes with foot ulcer due to callus deteriorationMakoto Oe, Kimie Takehara, Hiroshi Noguchi, et al.
Diabetology International|January 4, 2019
Effects of switching to low-dose rosuvastatin (5 mg/day) on glucose metabolism and lipid profiles in Japanese patients with type 2 diabetes and dyslipidemia: a single-arm, prospective, interventional trialAkiko Kameda, Akinobu Nakamura, Yoshinobu Kondo, et al.
Diabetology International|January 4, 2019
Different effects of linagliptin and sitagliptin on blood pressure and renal function in Japanese patients with type 2 diabetes mellitusMasayuki Tojikubo, Yuji Tajiri
Diabetology International|January 4, 2019
Sarcopenia in elderly patients with type 2 diabetes mellitus: prevalence and related clinical factorsYuko Murata, Yoshiki Kadoya, Shoichi Yamada, et al.
Diabetology International|January 4, 2019
IAPP/amylin and β-cell failure: implication of the risk factors of type 2 diabetesAzuma Kanatsuka, Shigetake Kou, Hideichi Makino
Diabetology International|January 4, 2019
Development of a novel estimation method for hemoglobin A1c using glycated albumin in type 2 diabetes mellitus patients with end-stage renal diseaseAkihiko Nakamura, Ryo Kodera, Noriko Sakamoto, et al.
Diabetology International|January 4, 2019
Low body mass index and old age are useful in predicting the hemoglobin A1c-lowering effect of switching from sitagliptin to dulaglutide in Japanese patients with type 2 diabetes mellitus: a single-center, open-label, single-arm, pilot studyTomoyuki Iwasaki, Takaomi Kessoku, Takuma Higurashi, et al.
Pageof 67